Key result
Women with polycystic ovary syndrome are at increased risk for nonalcoholic fatty liver disease, driven by insulin resistance and hyperandrogenemia, warranting screening in high-risk patients.
Population
Women with polycystic ovary syndrome (PCOS)
Design
Review
Authors
Loading...
May warrant NAFLD evaluation in PCOS; leaves open causal links and need for prospective validation.
Clinicians should be aware of the connection between PCOS and NAFLD and consider screening high-risk patients.
Carly E. Kelley (2014) conducted a review in Polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease (NAFLD). Polycystic ovary syndrome (PCOS) was evaluated. Women with polycystic ovary syndrome are at increased risk for nonalcoholic fatty liver disease, driven by insulin resistance and hyperandrogenemia, warranting screening in high-risk patients.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: